...
首页> 外文期刊>Haematologica >Successful treatment with T depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura | Haematologica
【24h】

Successful treatment with T depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura | Haematologica

机译:T耗尽自体外周血干细胞移植治疗难治性慢性自身免疫性血小板减少性紫癜的成功治疗血液学

获取原文
           

摘要

Autoimmune thrombocytopenia (AITP) is a disorder due to specific platelet auto-antibodies directed against platelet surface glycoproteins. AITP in adults is usually chronic, idiopathic and frequently refractory to conventional treatments. Myelo- and immuno- suppressive chemotherapy followed by autologous peripheral blood stem cell (PBSC) transplantation is an experimental approach for severe chronic refractory AITP. We report a case of a woman with AITP, refractory to the conventional therapy, submitted to T-cell-depleted autologous PBSC transplantation, which obtained long term stable response on platelet count. We deem that the positive outcome of our patient depends on T-cells depletion of the graft, which reduces autoreactive T clones.
机译:自身免疫性血小板减少症(AITP)是一种由于针对血小板表面糖蛋白的特异性血小板自身抗体而引起的疾病。成人的AITP通常是慢性的,特发性的,并且通常难以接受常规治疗。骨髓抑制和免疫抑制化学疗法以及自体外周血干细胞(PBSC)移植是重度慢性难治性AITP的实验方法。我们报道一例患有AITP的女性,对传统疗法无效,该患者接受了T细胞耗竭的自体PBSC移植,该移植获得了血小板计数的长期稳定反应。我们认为我们患者的阳性结果取决于移植物的T细胞耗竭,这会减少自身反应性T克隆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号